Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenic cytokines are a group of paracrine signaling molecules that regulate angiogenesis, the formation of new blood vessels. These cytokines, including VEGFs, angiopoietins, TGF-β, FGFs, and certain pro-inflammatory cytokines, act on nearby cells to stimulate endothelial cell proliferation, migration, and differentiation. Dysregulation of angiogenic cytokine signaling is implicated in various diseases, including cancer, cardiovascular disease, and wound healing, making them important therapeutic targets.
Not Applicable
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenic Cytokines.